EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Track record

Tools

  • Compare
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›ACON

ACON

Aclarion, Inc.

Next earnings ≈ Aug 12, 2026 · est. from filing cadence

Hold
$2.85
▲ +5.17%
$2.85▼ -60.53%
over 1Y
L $2.36EODHDH $9.40
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+5.2%
1W+5.2%
1M-8.7%
3M-6.9%
YTD-42.8%
1Y-60.5%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Hold
Quality
D
Valuation
Fair value
Filings
Clean
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 7 analysts
Buy

Revenue grew 65.6% YoY; but unprofitable (net margin -9551.9%).

Aclarion, Inc. shows $75.7K in FY2025 revenue (+65.6% YoY), a -9551.9% net margin, and -56.4% ROE.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$60.3K$60.4K$75.4K$45.7K$75.7K
Gross profit-$8.88K-$4.85K-$324.00-$38.9K$6.83K
Operating income-$2.95M-$5.56M-$4.88M-$5.51M-$7.05M
Net income-$4.95M-$7.07M-$4.91M-$6.99M-$7.23M
Diluted EPS-$6.58-$19.61-$79,782.00-$7,478.90-$13.61
Net margin-8210.5%-11694.4%-6513.4%-15293.8%-9551.9%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value-$5.51M
EV / EBITDA—
EV / Sales-72.8
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-111.2%
FCF yield-110.5%

Quality & risk

ROIC (est.)-43.4%
Free cash flow-$7.19M
Total debt—
Net cash$12.0M
Altman Z-Score-2.01 distress
Piotroski F-Score4/8

Capital returns

Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+291.9%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Routine disclosure cadence — no material red flags in recent filings.
  1. 8-K Shareholder vote2026-06-04
  2. 10-Q Quarterly report2026-05-13
  3. DEF 14A Proxy statement2026-04-27
  4. 8-K Other event2026-04-22
  5. 8-K Material agreement2026-03-19
  6. 10-K Annual report2026-03-18
  7. 8-K Reg FD disclosure2026-01-13
  8. 8-K Material agreement2026-01-09
  9. 10-Q Quarterly report2025-11-12

Recent filings

all on EDGAR ↗
4Period ending 2026-06-112026-06-12open ↗4Period ending 2026-06-112026-06-12open ↗4Period ending 2026-06-112026-06-12open ↗4Period ending 2026-06-112026-06-12open ↗4Period ending 2026-06-112026-06-12open ↗4Period ending 2026-06-112026-06-12open ↗4Period ending 2026-06-112026-06-12open ↗4Period ending 2026-06-112026-06-12open ↗4Period ending 2026-06-112026-06-12open ↗8-KPeriod ending 2026-06-042026-06-04open ↗10-QPeriod ending 2026-03-312026-05-13open ↗4Period ending 2026-05-122026-05-12open ↗

Quality score

D
ValueGrowthProfitHealthMom.
ValueF
GrowthB-
ProfitabilityF
Financial healthB-
Momentum—
  • ✓Revenue growing year-over-year
  • ✗Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
  • ✓Liabilities below 2× equity
Revenue
$75.7K
+65.6% YoY
Net margin
-9551.9%
ROE
-56.4%
P/E
—

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$75.7K+65.6%
Net income-$7.23M-3.4%
Gross profit$6.83K+117.5%
Operating income-$7.05M-27.9%
Diluted EPS-$13.61+99.8%
Cash & equivalents$12.0M+2548.6%
Total assets$13.7M+543.9%
Total liabilities$837K-27.4%
Stockholders' equity$12.8M+1223.1%
Gross: 9.0%Op.: -9312.5%L/E: 0.07x

Frequently asked

Is Aclarion, Inc. (ACON) a buy?
ACON currently carries a Hold rating with 2/5 conviction, derived from its latest SEC filings. Revenue grew 65.6% YoY; but unprofitable (net margin -9551.9%).
What is Aclarion, Inc.'s quality score?
ACON scores 42.05882352941176/100 (grade D) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001635077, latest 10-Q filed 2026-05-13) · EODHD · as of 6/26/2026, 8:07:28 PM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2026-06-11
Bond Ryan
Chief Strategy Officer
Award55.0K
2026-06-11
Sequira Amanda Mae
Director
Award20.0K
2026-06-11
Breidbart Scott
Director
Award20.0K
2026-06-11
Gould Gregory A
Chief Financial Officer
Award50.0K
2026-06-11
Ness Brent
Chief Executive Officer
Award100K
2026-06-11
Wesemann William
Director
Award20.0K
2026-06-11
Thramann Jeffrey John
Executive Chairman
Award100K
2026-06-11
Neal David K
Director
Award20.0K

Earnings history

beat/miss · move
2024-02-21—▼ -7.19%8-K ↗
2023-08-25—▼ -2.17%8-K ↗
2023-05-23—▼ -9.93%8-K ↗
2023-05-16—▼ -6.76%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Recent news

market news →
Aclarion to Present at the Planet MicroCap Las Vegas Powered by MicroCapClubBullish
globenewswire.com· 2026-06-10
Natera (NTRA) Reports Q1 Loss, Tops Revenue EstimatesBullish
finance.yahoo.com· 2026-05-07
Aclarion Announces Second Commercial Agreement with Weill Cornell MedicineBullish
globenewswire.com· 2026-05-05
Aclarion Delivers Strong Q1 2026 Results with 196% Annual Scan Volume Growth Reflecting Accelerating Clinical AdoptionBullish
globenewswire.com· 2026-04-30
Aclarion Authorized To Repurchase Up To $2.5 Mln Of SharesBullish
nasdaq.com· 2026-04-22
Aclarion to Participate in the 38th Annual ROTH Conference, Highlighting Key 2026 Catalysts and Strong Balance SheetBullish
globenewswire.com· 2026-03-17

Vs tracked universe

compare →

1044 tracked peers · median

EDGAR Score42 vs 67
Revenue growth65.6% vs 7.1%
Net margin-9551.9% vs 10.5%
Return on equity-56.4% vs 12.3%
P/E— vs 25.5

News sentiment

EODHD · 4d
Bullish
+0.17
vs typical · 4 articles
↑ improving

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.